Carcinosarcoma — Trials

Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

77 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 22
Recruiting: 13
Ph III recruiting: 5
Growth YoY: —
Industry share: 5%
Top sponsor: Mayo Clinic
Termination share: 46.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 51–77 of 77 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05537844	Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma(BriTROC-2)	unknown	—	250	Liz-Anne LewsleyOTHER	1	Sep 23, 2022	clinicaltrials
NCT03924245	Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers	terminated	Phase 1	3	Vanderbilt-Ingram Cancer CenterOTHER	1	Apr 4, 2022